Serum Asymmetric Dimethylarginine Levels in Patients with Acute Rheumatic Fever: Inflammation and Endothelial Dysfunction

Journal of Pediatric Biochemistry 2015; 05(01): 001
DOI: 10.1055/s-0035-1554730

Editorial

Georg Thieme Verlag KG Stuttgart · New York

Mahboob Alam

¹Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, United States

References
1 Antoniades C, Antonopoulos AS, Bendall JK, Channon KM. Targeting redox signaling in the vascular wall: from basic science to clinical practice. Curr Pharm Des 2009; 15 (3) 329-342
2 Antoniades C, Shirodaria C, Leeson P , et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J 2009; 30 (9) 1142-1150
3 Sydow K, Hornig B, Arakawa N , et al. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. Vasc Med 2004; 9 (2) 93-101
4 Melikian N, Wheatcroft SB, Ogah OS , et al. Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young Black African men. Hypertension 2007; 49 (4) 873-877
5 Juonala M, Viikari JS, Alfthan G , et al. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study. Circulation 2007; 116 (12) 1367-1373
6 Böger RH, Maas R, Schulze F, Schwedhelm E. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—an update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 2009; 60 (6) 481-487
7 Sert A, Cimen D, Arslan D , et al. Serum asymmetric dimethylarginine levels in patients with acute rheumatic fever. J Pediat Biochem 2015; 5 (1) 21-27